Chemoinformaics analysis of Cryptomerione
Molecular Weight | 218.34 | nRot | 4 |
Heavy Atom Molecular Weight | 196.164 | nRig | 9 |
Exact Molecular Weight | 218.167 | nRing | 1 |
Solubility: LogS | -3.3 | nHRing | 0 |
Solubility: LogP | 3.946 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 40.5214 |
nHD | 0 | BPOL | 22.9386 |
QED | 0.65 |
Synth | 4.135 |
Natural Product Likeliness | 2.729 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.035 |
Pgp-sub | 0.004 |
HIA | 0.007 |
CACO-2 | -4.517 |
MDCK | 0.0000208 |
BBB | 0.992 |
PPB | 0.942208 |
VDSS | 2.126 |
FU | 0.0839551 |
CYP1A2-inh | 0.523 |
CYP1A2-sub | 0.434 |
CYP2c19-inh | 0.197 |
CYP2c19-sub | 0.604 |
CYP2c9-inh | 0.133 |
CYP2c9-sub | 0.228 |
CYP2d6-inh | 0.048 |
CYP2d6-sub | 0.269 |
CYP3a4-inh | 0.364 |
CYP3a4-sub | 0.246 |
CL | 15.766 |
T12 | 0.389 |
hERG | 0.005 |
Ames | 0.155 |
ROA | 0.226 |
SkinSen | 0.081 |
Carcinogencity | 0.462 |
EI | 0.427 |
Respiratory | 0.959 |
NR-Aromatase | 0.005 |
Antiviral | Yes |
Prediction | 0.841701 |